How Can Healthcare Providers Order the CIZ1B Lung Cancer Blood Test?
Short answer
Licensed healthcare providers in the Dallas-Fort Worth and San Antonio metropolitan areas can begin CIZ1B ordering setup by completing a provider account setup process. Once onboarding is complete, providers can access the provider portal to place CIZ1B orders and receive results.
CIZ1B is designed to provide an additional biomarker-based data point that may support lung cancer assessment alongside clinical judgment, LDCT or other imaging, patient history, symptoms, risk factors, and other relevant clinical information.
Who can order CIZ1B?
CIZ1B is ordered by licensed healthcare providers.
Patients who are interested in CIZ1B should speak with their healthcare provider about whether it may be appropriate for their situation.
Where is CIZ1B currently available?
CIZ1B is currently available through licensed healthcare providers in the Dallas-Fort Worth and San Antonio metropolitan areas.
How does provider ordering setup work?
The ordering setup process is designed to establish provider access before orders can be placed.
Step 1: Review clinical resources
Before beginning setup, providers may want to review:
what CIZ1B is designed to measure,
how CIZ1B may support lung cancer assessment,
how CIZ1B complements LDCT and other clinical information,
potential patient considerations,
specimen collection information,
ordering and result access workflow.
Step 2: Start provider account setup
The provider account setup process collects the practice and provider information needed to establish access.
Step 3: Receive onboarding instructions
After submitting the required setup information, a representative will follow up with next steps. This may include instructions for provider portal access and onboarding.
Step 4: Complete onboarding
The onboarding process may review:
provider portal access,
ordering workflow,
specimen collection,
shipping logistics,
expected turnaround,
accessing results,
support contacts.
Step 5: Place CIZ1B orders
Once account setup and onboarding are complete, providers can place CIZ1B orders and receive results through the provider portal.
How should CIZ1B results be interpreted?
CIZ1B results should be interpreted as part of a comprehensive clinical assessment. A provider may consider the result alongside:
patient history,
symptoms,
risk factors,
LDCT or other imaging,
specialist evaluation,
additional testing when clinically indicated.
CIZ1B is not intended to replace LDCT, imaging, biopsy, specialist evaluation, or clinical judgment.
What clinical scenarios may be relevant?
Healthcare providers may consider CIZ1B as an additional biomarker-based data point in scenarios such as:
patients with lung cancer risk factors,
patients with symptoms requiring assessment,
patients with imaging findings requiring clinical context,
screening-eligible patients unable or unwilling to complete LDCT,
patients with indeterminate pulmonary nodules,
patients with occupational or environmental exposures,
longitudinal surveillance when clinically appropriate.
Provider next step
Licensed healthcare providers in Dallas-Fort Worth and San Antonio can review ordering setup steps and begin provider onboarding.
FAQ
Can patients order CIZ1B directly?
CIZ1B is ordered through licensed healthcare providers. Patients should talk with their healthcare provider about whether CIZ1B may be appropriate.
Does CIZ1B replace LDCT?
No. CIZ1B is designed to complement LDCT and other clinical information, not replace it.
What happens after provider setup is submitted?
A representative will follow up with next steps for account setup, provider portal access, and onboarding.
How do providers ask clinical questions?
For questions about clinical use of the CIZ1B Biomarker Blood Test for Lung Cancer, licensed healthcare providers may contact the Cizzle Bio Medical Affairs team at clinicians@cizzlebio.com.
